KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Vertex Pharmaceuticals (VRTX) Leases (2016 - 2025)

Historic Leases for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q4 2025 value amounting to $1.6 billion.

  • Vertex Pharmaceuticals' Leases rose 1517.54% to $1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year increase of 1517.54%. This contributed to the annual value of $1.6 billion for FY2025, which is 1517.54% up from last year.
  • According to the latest figures from Q4 2025, Vertex Pharmaceuticals' Leases is $1.6 billion, which was up 1517.54% from $1.6 billion recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Leases registered a high of $1.6 billion during Q3 2025, and its lowest value of $293.6 million during Q4 2023.
  • For the 5-year period, Vertex Pharmaceuticals' Leases averaged around $669.8 million, with its median value being $339.5 million (2022).
  • Per our database at Business Quant, Vertex Pharmaceuticals' Leases tumbled by 1548.65% in 2023 and then soared by 36212.53% in 2024.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Leases stood at $400.1 million in 2021, then dropped by 13.17% to $347.4 million in 2022, then dropped by 15.49% to $293.6 million in 2023, then surged by 362.13% to $1.4 billion in 2024, then grew by 15.18% to $1.6 billion in 2025.
  • Its Leases stands at $1.6 billion for Q4 2025, versus $1.6 billion for Q3 2025 and $1.3 billion for Q2 2025.